Physician profile
Norma Ann Bracamonte
NPI 1851757603
$1,143.82
in general payments reported to CMS, 2019-2025
17 companies · $759 in 2025
The $759 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.46 · 2022: $33.93 · 2023: $41.47 · 2024: $238 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $374.06 | 2024-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $125.53 | 2024-2025 | |
| Csl Behring | $111.63 | 2024-2025 | Hizentra, Andembry, Haegarda |
| Regeneron Healthcare Solutions, INC. | $110.88 | 2025 | Dupixent |
| Genentech USA, INC. | $62.85 | 2024-2025 | Xolair |
| Smith+Nephew, INC. | $60.26 | 2021-2024 | Grafix Pl |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.73 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.93 | 2024 | Cuvitru, Glassia |
| Janssen Pharmaceuticals, INC | $45.23 | 2021-2023 | Xarelto |
| Ars Pharmaceuticals Operations, INC. | $25.72 | 2025 | Neffy |
| Biocryst US Sales Co., LLC | $23.52 | 2025 | Orladeyo |
| Lilly USA, LLC | $23.29 | 2025 | Ebglyss |
| Galderma Laboratories, L.P. | $21.69 | 2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $18.13 | 2025 | |
| Exact Sciences Corporation | $17.04 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.45 | 2025 | Nucala |
| Nestle Healthcare Nutrition INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Bracamonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.